HCA Healthcare, Inc. (NYSE:HCA) Position Lowered by Mn Services Vermogensbeheer B.V.

Mn Services Vermogensbeheer B.V. reduced its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.1% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 73,300 shares of the company's stock after selling 5,600 shares during the period. Mn Services Vermogensbeheer B.V.'s holdings in HCA Healthcare were worth $25,329,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Tuttle Capital Management LLC lifted its holdings in HCA Healthcare by 68.9% in the first quarter. Tuttle Capital Management LLC now owns 1,782 shares of the company's stock valued at $616,000 after acquiring an additional 727 shares during the period. Optas LLC purchased a new stake in HCA Healthcare during the first quarter worth about $222,000. Asio Capital LLC lifted its position in shares of HCA Healthcare by 0.5% during the 1st quarter. Asio Capital LLC now owns 17,062 shares of the company's stock valued at $5,896,000 after acquiring an additional 79 shares during the period. Brighton Jones LLC increased its stake in HCA Healthcare by 1.6% in the 1st quarter. Brighton Jones LLC now owns 3,458 shares of the company's stock valued at $1,195,000 after purchasing an additional 56 shares in the last quarter. Finally, Exchange Traded Concepts LLC boosted its position in HCA Healthcare by 803.4% during the first quarter. Exchange Traded Concepts LLC now owns 14,526 shares of the company's stock worth $5,019,000 after purchasing an additional 12,918 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company's stock.

HCA Healthcare Trading Down 0.2%

NYSE:HCA traded down $0.91 on Friday, hitting $370.76. 872,296 shares of the stock were exchanged, compared to its average volume of 1,452,711. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market cap of $89.20 billion, a PE ratio of 16.88, a PEG ratio of 1.10 and a beta of 1.49. The stock has a fifty day moving average of $358.43 and a 200-day moving average of $333.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.75 by $0.70. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. The company had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. During the same quarter in the prior year, the business earned $5.36 earnings per share. The business's quarterly revenue was up 5.7% compared to the same quarter last year. As a group, equities analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a yield of 0.78%. The ex-dividend date of this dividend is Monday, June 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.81%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on HCA shares. Wells Fargo & Company upgraded shares of HCA Healthcare from an "underweight" rating to an "equal weight" rating and raised their target price for the company from $320.00 to $385.00 in a report on Thursday, May 29th. Guggenheim started coverage on HCA Healthcare in a research note on Wednesday, April 9th. They issued a "neutral" rating on the stock. Baird R W cut HCA Healthcare from a "strong-buy" rating to a "hold" rating in a report on Tuesday, April 15th. Royal Bank of Canada dropped their price objective on HCA Healthcare from $384.00 to $376.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Finally, Morgan Stanley set a $410.00 price target on shares of HCA Healthcare and gave the stock an "equal weight" rating in a research note on Monday, June 9th. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the company's stock. Based on data from MarketBeat, HCA Healthcare has an average rating of "Moderate Buy" and a consensus price target of $392.47.

Insider Activity

In other HCA Healthcare news, COO Jon M. Foster sold 15,698 shares of the firm's stock in a transaction that occurred on Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total transaction of $5,797,585.36. Following the completion of the sale, the chief operating officer now owns 12,646 shares in the company, valued at $4,670,420.72. This trade represents a 55.38% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.30% of the company's stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.